These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 34261899)
1. Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer. Peters EEM; León-Castillo A; Smit VTHBM; Boennelycke M; Hogdall E; Hogdall C; Creutzberg C; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JWM; Lutgens LCHW; van der Steen-Banasik EM; Ortoft G; Bosse T; Nout R Int J Gynecol Pathol; 2022 May; 41(3):220-226. PubMed ID: 34261899 [TBL] [Abstract][Full Text] [Related]
2. Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution study. Pifer PM; Bhargava R; Patel AK; Ling DC; Vargo JA; Orr BC; Sukumvanich P; Courtney-Brooks MB; Boisen MM; Berger JL; Taylor S; Olawaiye AB; Comerci JT; Lesnock JL; Edwards RP; Beriwal S Gynecol Oncol; 2020 Oct; 159(1):23-29. PubMed ID: 32718729 [TBL] [Abstract][Full Text] [Related]
3. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials. Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688 [TBL] [Abstract][Full Text] [Related]
4. Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer? Jaishankar S; Pifer PM; Bhargava R; Keller A; Musunuru HB; Patel AK; Sukumvanich P; Boisen M; Berger JL; Taylor S; Courtney-Brooks M; Olawaiye A; Lesnock J; Edwards R; Vargo JA; Beriwal S Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):452-458. PubMed ID: 35264314 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of three-tiered scoring system for lymph-vascular space invasion in endometrial cancer: A systematic review and meta-analysis. Han L; Chen Y; Zheng A; Tan X; Chen H Gynecol Oncol; 2024 May; 184():198-205. PubMed ID: 38335803 [TBL] [Abstract][Full Text] [Related]
6. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407 [TBL] [Abstract][Full Text] [Related]
7. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study. Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248 [No Abstract] [Full Text] [Related]
8. Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer. Peters EEM; Bartosch C; McCluggage WG; Genestie C; Lax SF; Nout R; Oosting J; Singh N; Smit HCSH; Smit VTHBM; Van de Vijver KK; Bosse T Histopathology; 2019 Jul; 75(1):128-136. PubMed ID: 31155736 [TBL] [Abstract][Full Text] [Related]
9. Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer. Peters EEM; Léon-Castillo A; Hogdall E; Boennelycke M; Smit VTHBM; Hogdall C; Creutzberg CL; Bosse T; Nout RA; Ørtoft G Int J Gynecol Pathol; 2022 May; 41(3):227-234. PubMed ID: 34392268 [TBL] [Abstract][Full Text] [Related]
10. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma. Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193 [TBL] [Abstract][Full Text] [Related]
11. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes. Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364 [TBL] [Abstract][Full Text] [Related]
12. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer. Jorge S; Hou JY; Tergas AI; Burke WM; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD Gynecol Oncol; 2016 Mar; 140(3):387-93. PubMed ID: 26768835 [TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma. Bhatnagar AR; Ghanem AI; Alkamachi B; Allo G; Lin CH; Hijaz M; Elshaikh MA Gynecol Oncol; 2024 Sep; 188():44-51. PubMed ID: 38936280 [TBL] [Abstract][Full Text] [Related]
14. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer. Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931 [TBL] [Abstract][Full Text] [Related]
15. Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer. Guntupalli SR; Zighelboim I; Kizer NT; Zhang Q; Powell MA; Thaker PH; Goodfellow PJ; Mutch DG Gynecol Oncol; 2012 Jan; 124(1):31-5. PubMed ID: 22030404 [TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of lympho-vascular space invasion in different molecular subtypes of endometrial carcinoma]. Li YM; Zhai ZY; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL Zhonghua Fu Chan Ke Za Zhi; 2024 Aug; 59(8):617-627. PubMed ID: 39187409 [No Abstract] [Full Text] [Related]
17. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer. Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915 [TBL] [Abstract][Full Text] [Related]
18. The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients. Ronsini C; Anchora LP; Restaino S; Fedele C; Arciuolo D; Teodorico E; Bizzarri N; Zannoni GF; Ferrandina G; Scambia G; Fanfani F Gynecol Oncol; 2021 Aug; 162(2):299-307. PubMed ID: 34116834 [TBL] [Abstract][Full Text] [Related]
19. A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion. Bendifallah S; Canlorbe G; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Huguet F; Cortez A; Daraï E; Ballester M Br J Cancer; 2014 May; 110(11):2640-6. PubMed ID: 24809776 [TBL] [Abstract][Full Text] [Related]
20. Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer. Zanfagnin V; Huang Y; Mc Gree ME; Weaver AL; Casarin J; Multinu F; Cappuccio S; Ferrero A; Mariani A; Glaser GE Gynecol Oncol; 2019 Sep; 154(3):480-486. PubMed ID: 31324453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]